<i>Porphyromonas</i> , a potential predictive biomarker of <i>Pseudomonas aeruginosa</i> pulmonary infection in cystic fibrosis
Marlène Keravec(Université de Bretagne Occidentale), Geneviève Héry-Arnaud, Charles-Antoine Guilloux(Inserm), Stanislas Mondot(AgroParisTech), S. Gouriou(Université de Bretagne Occidentale), Georges Barbier(Ifremer), Rozenn Le Berre(Inserm), Claude Férec(Université de Bretagne Occidentale), Marie-Sarah Fangous(Hôpital Femme Mère Enfant), Jérôme Mounier(Université de Bretagne Occidentale), G. Rault(ManRos Therapeutics (France)), Sophie Vallet(Inserm), Patricia Lepage(Département Génétique Animale)
Cited by 21
Related Papers
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis
|Journal of Innate Immunity|2016|5k
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
|Annals of Oncology|2017|1.3k
ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF
|Nature Genetics|2000|438
The origin of the major cystic fibrosis mutation (ΔF508) in European populations
|Nature Genetics|1994|347